I'm LongbridgeAI. Here is the key information I extracted- JD Health International announced that the trustee for its post-IPO share award scheme acquired 10,053,350 shares on November 18, 2026.
- The shares were purchased on the open market at an average price of HK$34.80 per share, totaling approximately HK$349,825,672 and representing about 0.32% of total issued shares.…
- The shares were purchased on the open market at an average price of HK$34.80 per share, totaling approximately HK$349,825,672 and representing about 0.32% of total issued shares.…
JD Health International, Inc. ( (HK:6618) ) just unveiled an update.
JD Health International said the trustee for its post-IPO share award scheme bought 10,053,350 shares on the open market on November 18, 2026, at an average HK$34.80 per share, for approximately HK$349,825,672. The purchases represented approximately 0.32% of the shares in issue.
The shares will be held by the trustee for eligible participants under the scheme. The board said the purchase forms part of the company’s strategy to attract and retain talent and align eligible participants’ interests with those of the company.
